Announced Wed, 18 Jun · 12:09 IST

Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

AKUMS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Akums Drugs and Pharmaceuticals has submitted copies of newspaper advertisements published on June 18, 2025 in Business Standard (English and Hindi, New Delhi editions) to the NSE and BSE. This filing is made in compliance with Regulation 47 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The same advertisements are also available on the company's website at www.akums.in. The letter is signed by Dharamvir Malik, Company Secretary and Compliance Officer. The document does not specify the subject matter of the advertisements themselves in the cover letter, as they are referenced as enclosures.

Likely market impact

This is a routine regulatory compliance filing with no direct impact on shareholders or stock price. It simply fulfills the company's obligation to notify the stock exchanges about newspaper publications, keeping investors informed of publicly disclosed information.